New Drug Platform Screening Zspeplib Completed $14 Million In Series A Financing

According to 36Kr, Zspeplib just completed around 14 million dollars in Series A financing. This round of financing was led by Tasly Group, and followed by Xiang Xiang Investment. The funds will be used to build a hexapeptide library, optimize the peptide new drug screening platform and develop new drugs.

Founded in 2017, Zspeplib is a company specializing in peptide lead drug discovery, focusing on the development, production and sales of large-capacity peptide libraries and new drug development. Zspeplib uses peptide information compression technology (PICT) to build a complete library of peptides with independent intellectual property rights. This technology can greatly reduce the cost of peptide library construction and the cost of new drug screening, and improve the efficiency of building a database by 6000 times.

Up to now, Zspeplib's PICT technology has applied for patents in China, the United States, Europe, Canada, Australia, Japan and other countries. It is reported that in recent years, the global peptide drug market has grown at a rate of more than 12%, and the market size is close to 20 billion dollars. According to Transparency Market Research, the global peptide drug market is expected to reach 23.7 billion dollars in 2020.

At present, there are only three companies in the world that use peptide libraries for new drug discovery, including Zspeplib, Japan's PeptiDream and UK's Bicycle Therapeutics. They all use novel peptide construction techniques to construct polypeptide molecules and build giant peptide libraries, greatly improving the diversity of compound libraries. At this moment, the company will screen new drugs for tumors, chronic inflammation, diabetes, cardiovascular and cerebrovascular diseases, and accelerate the development of the production pipeline.

Tasly Group is an internationalized and high-tech cooperation, engaging in the pan-health industry with the biological medicine industry as the core business.

Founded in 2009, Xiang Xiang Investment is a Chinese state-own investment company that was backed by Hunan Provincial Government.